Nicotine and Cotinine, Blood


Abbrev Code:NICTI   
Order Code:LAB1145Order Name:Nicotine & Mets, S/P, Quant
Methodology:Quantitative liquid chromatography/Tandem mass spectrometry
CPT Codes: 80323 x1, 80323 x1
Turnaround Time:Specimens are sent to the reference laboratory Sun-Sat; results are reported within 1-4 days.
Compliance:

ARUP Laboratory Developed Test (LDT): For tests developed and validated by ARUP (previously referred to as Compliance Statement B, C or D). This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.



Collection Instructions

Specimen:Blood
Optimal Volume:8 mL
Minimum\Peds Volume:2.2 mL
Container:Red (no gel)
Alternate Containers: Green (sodium heparin, no gel), Purple (EDTA), Red or gold (gel)
Causes for Rejection:Collected in light blue (sodium citrate). Specimens exposed to repeated freeze/thaw cycles. Hemolyzed specimens.


Processing and Shipping

Specimen Processing:Separate serum or plasma from cells ASAP or within 2 hours of collection. Centrifuge and aliquot 4 mL, 1.0 mL minimum serum or plasma. Store in refrigerator.
Shipping Instructions:Ship at refrigerated temperature.
Stability:After separation from cells: 1 week at room temperature; 2 weeks refrigerated; 3 years frozen.
Test Performed at or Referral Lab Lab Sendouts  (ARUP)
Referral Lab number:0092361, NICOTINSP


Interpretive

Reference Range:Effective August 15, 2022:
Positive cutoff: 5 ng/mL

Cutoff Concentrations:
Nicotine: 5 ng/mL
Cotinine (metabolite): 5 ng/mL
Use:For medical purposes only, not valid for forensic use.

This test is designed to evaluate recent use of nicotine-containing products. Passive and active exposure cannot be discriminated definitively, although a cutoff of 10 ng/mL cotinine is frequently used for surgery qualification purposes.  For smoking cessation programs or compliance testing, the absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor absorption, or limitations of testing. This test cannot distinguish between use of tobacco or purified nicotine products. The concentration value must be greater than or equal to the cutoff to be reported as positive.


Click HERE to Report test errors or omissions.
*If no email program is associated with this computer, please contact:
systemlabguide@fairview.org for TestID: 2754"